🇺🇸 FDA
Patent

US 9199975

Biaryl imidazole derivatives for regulating CYP17

granted A61PA61P35/00

Quick answer

US patent 9199975 (Biaryl imidazole derivatives for regulating CYP17) held by Asana BioSciences, LLC expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Asana BioSciences, LLC
Grant date
Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P35/00